Related references
Note: Only part of the references are listed.Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation
Andreas H. Groll et al.
LANCET ONCOLOGY (2014)
Candidaemia in a Polish tertiary paediatric hospital, 2000 to 2010
Katarzyna Dzierzanowska-Fangrat et al.
MYCOSES (2014)
Deoxycholate Amphotericin B and Nephrotoxicity in the Pediatric Setting
David F. Bes et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2014)
Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity
Richard J. Hamill
DRUGS (2013)
Role of diuretics and lipid formulations in the prevention of amphotericin B-induced nephrotoxicity
Iman Karimzadeh et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.
W. W. Hope et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Amphotericin B in neonates: deoxycholate or lipid formulation as first-line therapy - is there a 'right' choice?
Anna Turkova et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2011)
Continuous infusion of amphotericin B deoxycholate: an innovative, low-cost strategy in antifungal treatment
Diego R. Falci et al.
MYCOSES (2011)
Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India
Shyam Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
Not Just Little Adults: Candidemia Epidemiology, Molecular Characterization, and Antifungal Susceptibility in Neonatal and Pediatric Patients
Christopher C. Blyth et al.
PEDIATRICS (2009)
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw et al.
CLINICAL INFECTIOUS DISEASES (2008)
Changing epidemiology of systemic fungal infections
M. Richardson et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Invasive fungal infections: a review of epidemiology and management options
D. A. Enoch et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
The hepatotoxicity of antifungal medications in bone marrow transplant recipients
MA Fischer et al.
CLINICAL INFECTIOUS DISEASES (2005)
Adverse effects of antifungal therapies in invasive fungal infections: review and meta-analysis
SB Girois et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial
U Eriksson et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients
PJ Cagnoni et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
